Clinical Trial Detail

Missing content? – Request curation!

Request curation for specific Genes, Variants, or PubMed publications.

Have questions, comments, or suggestions? - Let us know!

NCT ID	NCT04985604
Title	Tovorafenib (DAY101) Monotherapy or in Combination With Other Therapies for Patients With Melanoma and Other Solid Tumors
Recruitment	Active, not recruiting
Gender	both
Phase	Phase Ib/II
Variant Requirements	Yes
Sponsors	Day One Biopharmaceuticals, Inc.
Indications	melanoma Advanced Solid Tumor
Therapies	Pimasertib + Tovorafenib Tovorafenib
Age Groups:	adult \| child \| senior
Covered Countries	USA \| FRA \| ESP \| CAN \| BEL \| AUS